Volitionrx (VNRX) Current Leases (2018 - 2025)

Volitionrx (VNRX) posted Current Leases of $54377.0 for Q4 2025, down 78.65% on a QoQ basis from $254644.0 in Q3 2025, and up 16.35% year-over-year from $46737.0 in Q4 2024.

Volitionrx (VNRX) Current Leases (2018 - 2025) Analysis & Trends

Volitionrx's Current Leases history runs 8 years deep, the most recent figure standing at $54377.0 for Q4 2025.

  • Quarterly Current Leases rose 16.35% year-over-year to $54377.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54377.0 (up 16.35% YoY) and the FY2025 annual result came in at $54377.0, up 16.35% from the prior year.
  • Current Leases was $54377.0 for Q4 2025 at Volitionrx, down from $254644.0 in the prior quarter.
  • Across five years, Current Leases topped out at $254644.0 in Q3 2025 and bottomed at $41693.0 in Q3 2022.
  • A 5-year average of $123093.5 and a median of $54377.0 in 2025 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2023 — Current Leases sank 80.19% — and 2025, when it surged 428.13%.
  • Volitionrx's Current Leases stood at $171166.0 in 2021, then jumped by 43.23% to $245163.0 in 2022, then sank by 80.19% to $48570.0 in 2023, then decreased by 3.77% to $46737.0 in 2024, then grew by 16.35% to $54377.0 in 2025.
  • Business Quant data shows VNRX's Current Leases at $54377.0 in Q4 2025, $254644.0 in Q3 2025, and $252013.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Volitionrx 109,643.10 -2.35 Mn - 54,377.00

Historic Data

Download Data
DateValue
Dec 31, 2025 54,377.00
Sep 30, 2025 254,644.00
Jun 30, 2025 252,013.00
Mar 31, 2025 224,690.00
Dec 31, 2024 46,737.00
Sep 30, 2024 219,060.00
Jun 30, 2024 47,718.00
Mar 31, 2024 47,875.00
Dec 31, 2023 48,570.00
Sep 30, 2023 46,279.00
Jun 30, 2023 218,142.00
Mar 31, 2023 46,917.00
Dec 31, 2022 245,163.00
Sep 30, 2022 41,693.00
Jun 30, 2022 44,293.00
Mar 31, 2022 46,656.00
Dec 31, 2021 171,166.00
Sep 30, 2021 124,872.00
Jun 30, 2021 157,911.00
Dec 31, 2020 59,930.00